(Received for publication, May 3, 1965) The mammalian fetus is affixed to the uterine wall in a manner in some ways similar to that of a homograft. Its genetic composition, except in inbred strains, differs from that of the mother, and the question arises as to how the fetus avoids the immunologic rejection which is the usual fate of homografts. Previous work has indicated that the explanation lies in the nature of the placental barrier (1) . It has been shown in various animals that fetal tissues are antigenic, and that the pregnant female is capable of an immune response. Despite these findings, the mammalian fetus under natural conditions seldom induces homograft immunity in the mother; the mother appears to be largely shielded from fetal homotransplantation antigens by the placental barrier. The mother can, however, be sensitized against her fetuses under experimental conditions. We (2) have carried out such studies, designed to test the ability of the fetus to survive in an immunologically hostile environment. Even under these conditions, the fetuses remain unharmed while in utero. This again appears to reflect a shielding afforded by the placental barrier, in this case protecting the fetuses against a maternal immunologic attack.
We wished to study more specifically the means by which the placenta afforded protection to the fetus. It is generally thought that homotransplantation immunity is mediated predominantly by ceils; under some experimental conditions, however, circulating antibody has been shown also to play a role (3) . The type of circulating antibody most clearly related to homotransplantation immunity is known as cytotoxic antibody. In the present study we have determined whether cytotoxic antibody was transmitted across the placenta from mother to fetus in rabbits. We have found that it was, even appearing in 8-dayold blastocyst fluid. In those instances in which the fetus was not a specific target for the antibody, fetal titers were at or slightly below those in the mothers. However, when the fetus was the specific target for the antibody, in many cases no antibody could be detected in fetal serum, suggesting that antibody transferred from the mother was fixed to fetal target sites. Nevertheless, even in these cases, cytotoxic antibody was incapable of either destroying or detectably damaging the fetuses. It appears that rabbit fetuses neither receive nor require protection against maternal cytotoxic antibody. 579
Methods
Plan of Study.--A female rabbit was made homograft sensitive against a male (Rabbit A)
by at least 3 skin homografts made at weekly intervals. The female was then bred, usually first to a different male (Rabbit B) against which she had not been sensitized. The ensuing pregnancy was called the non-sensitized pregnancy (NS). Following completion of this pregnancy, she was then mated to the sensitizing male (Rabbit A) for a second pregnancy cal]ed the sensitized pregnancy (S). During each pregnancy, an additional graft from Rabbit A was placed on the female to maintain sensitization. On the day of birth in each pregnancy, the young were weighed, and then bled from the heart. A maternal blood specimen was taken at the same time. From these samples, serum for cytotoxic antibody titration was obtained. Nine pairs of pregnancies were studied. In the last 5 of these, 3 additional maternal serum specimens were taken: (a) before any grafts had been made from the sensitizing male; (b) after the 3 initial sensitizing grafts but before the first mating; and (c) before the second mating.
In 4 of the 9 pairs of pregnancies, additional observatiorts were made on the newborn rabbits: a white blood cell count was made (counting 2 chambers of 9 large squares each), a differential count determined (counting 100 cells) and the spleen and thymus weighed on a torsion balance.
Cytotoxic antibody titers were determined on the various sera, using a method modified from those of Gorer and O'Gorman (4), and of Boyse (5) . Preparation of Complement.--A minimum of 6 rabbits were bled, the blood allowed to clot at room temperature, and the separated serum removed repeatedly over a period of about 2 hours as the clot retracted. The serum was iced as it was collected and then spun at the end of the collection period at 0°C in a refrigerated centrifuge at 600 P.P~t for 10 minutes, 1500 ~M for 5 minutes, and 2500 ~ for 5 minutes. The clear supernatant was then removed and frozen immediately in 2 cc batches. No sample was thawed and frozen a second time before use.
Preparation of Trypan
Preparation of Cells.--A lymph node was removed from the sensitizing male and placed immediately in iced Hunk's solution at pH 7.3-7.4. Location and removal of the node was made much simpler by injecting 1 cc of an emulsion made from equal parts of complete Freund's adjuvant and water. Injection was made into the web between the toes 1 to 2 weeks prior to removal of a node behind the knee. The node was cleaned of gross blood and then teased open with 2 needles in 2 or 3 cc of iced Hank's solution. The resulting somewhat cloudy suspension of ceils was spun at <400 ~r for 15 seconds to sediment coarse particles. The supernatant, still containing the cell suspension, was decanted into a second centrifuge tube and spun at 400 RPM in an unrefrigerated International size 2 centrifuge (International Equipment Company, Boston) for 4 or 5 minutes, sufficient to sediment loosely a small button of white cells. The supernatant was discarded and the cells resuspended in 5 or 6 cc of iced Hank's solution, a cell count made, and the volume of cell suspension adjusted with Hunk's solution to give a final cell count of about 500 white cells/mm 3. The cells were kept iced except during centrifuging from the time of removal of the node until the cells were used. The preparation time was usually less than 1 hour.
Preparation of Sera.--All sera were inactivated at 56°C for 30 minutes and then kept frozen until used. Serial dilutions (full strength, 1:2, 1:4, 1:16, 1:64) were made in an ice bath, using 0.9 per cent NaCI as the diluent and making up to a total volume of 0.1 ce in each tube. 0.1 cc of the cell suspension was added and the tubes placed in a humidified incubator set at 37°C for 20 minutes. Following this incubation, 0.1 cc of our own preparation of pooled rabbit serum was added as a source of complement and incubation continued for an additional 40 minutes. The tubes were removed from the incubator, 0.1 cc of a freshly prepared dilution of 0.16 per cent trypan blue added, and after 10 to 15 minutes standing at room temperature the tubes were placed in an ice bath. A wet smear was made from each tube TABLE I
Cytotoxic Antibody Titers in Mothers and Newborn Babies from 9 Pairs of Pregnancies
Homograft sensitivity had been induced in the mother by skin grafting against a male (male A). In the non-sensitized pregnancy, the grafted mother was mated to another male (male B) from which no grafts had been made. In the sensitized pregnancy, the mother was mated to male A. Her offspring were genetically related to male A and were appropriate targets for maternal immunity. The non-sensitized pregnancy preceded the sensitized in all experiments except 1 and 2. * Ma, mother's serum taken before skin grafting; Mb, mother's serum taken after grafting and before mating; Me, mother's serum taken after delivery; Be, baby's serum taken after delivery. 
immediately before counting by shaking a small drop into a shallow well made on a microscope slide with a vaseline ring about 1 cm in diameter. The preparation was covered with a coverslip. The per cent of white cells stained by dye was then determined under 450 X magnification, using a light source without a blue filter. In addition to the various test sera, some of which served as controls, an additional control made from the pooled sera of several ungrafted rabbits was included with each run. The per cent of stained cells in this control was always (15 per cent. A positive test was one in which ~30 per cent of cells were stained.
Blastocyst fluid was obtained as described by Brambell and eoworkers (6) by removing the uterus from an 8-day-old pregnant doe, freezing it in methyl butane cooled to about --40°C with dry ice, and then in a cold room chipping away the tissue surrounding the frozen blastocyst fluid. At the proper temperature, easily found by trial, good cleavage of tissue from the frozen fluid could be obtained. Material from about 6 blastocysts in each pregnancy was pooled. The thawed but still cold fluid was centrifuged for 20 minutes at 0°C at 10,000 gym in an International PR-2 refrigerated centrifuge using the high speed head. The supernatant was tested for cytotoxic antibody titer in the same manner as serum.
RESULTS
Cytotoxic antibody titers obtained in 9 pairs of pregnancies are shown in Table I . In the 9 non-sensitizing pregnancies, 18 babies were tested. Sixteen (89 per cent) had antibody titers either at or within 1 dilution of the maternal titer, and 2 had zero titers. In the 9 sensitizing pregnancies, 19 babies were tested. One was excluded because the maternal titer was zero, 4 had titers at or within 1 dilution of maternal titers, 3 had titers 2 or more dilutions below maternal titers, and 11 (61 per cent) had zero titers.
Antibody titers were measured in blastocyst fluid on 2 occasions (Table II) , in one instance in a sensitized pregnancy and in one a non-sensitized pregnancy.
TABLE II Cytotoxic Antibody Titers in 8-Day-Old Blastocyst Fluid Compared with Simultaneous
Maternal Serum Titers In family 5 the blastocysts were not potential targets of maternal cytotoxic antibody (non-sensitized pregnancy) and in family 6, they were (sensitized pregnancy), but in both instances maternal serum and blastocyst fluid had titers at or within one dilution of each other.
Family 5
Non-sensitized pregnancy 
TABLE III Spleen and Thymus Weights and Total Blood Leukocyte and Blood Mononuclear Cell Counts in Neonatal Rabbits Born of 2 Kinds of Pregnancy
In the non-sensitized pregnancy, the neonatal rabbits were not appropriate targets for maternal cytotoxic antibody, whereas in the sensitized pregnancy they were. The various parameters are not significantly different in the 2 kinds of pregnancy. Sensitized  pregnancy  pregnancy   SD   2 to46  17  25  149  3227  1075   9  28  2524  874   8D   5 to47  24  29  8  158  11  1912  337  593  196 In both instances, blastocyst fluid titers were at or within 1 dilution of maternal serum fiters. Data on spleen and thymus weights and white cell and lymphocyte counts obtained from the newborn rabbits in 4 pairs of pregnancies are shown in Table  III . Differences in organ weights, expressed as rag./100 gm. body weight, are small and not significant. Differences in white and lymphocyte counts are larger but also not significant. In both sensitized and non-sensitized pregnancies, these values for total white cell and lymphocyte counts in neonatal rabbits are well below normal adult values, but in keeping with values for neonatal rabbits found by others (7).
Non-sensitized

DISCUSSION
Our findings have shown that cytotoxic antibody, a circulating antibody which under some circumstances has been implicated in homotransplantation immunity, was transmitted from mother to fetus in rabbits. When the fetus was not a specific target for maternal cytotoxic antibody (as in the non-sensitized pregnancies), the levels attained in the fetus usually (89 per cent of cases) were at or near maternal levels. But when the fetus was an appropriate target for the maternal antibody (as in the sensitized pregnancies), antibody in the fetus was frequently (61 per cent of cases) at an immeasurably low value, suggesting that the antibody was fixed to antigenic sites in the fetus and thereby removed from the fetal circulation. Despite this indication of reaction of antibody with the fetus, there was no evidence that the fetus was in any way either harmed or changed. It has been recognized for several years that some cell types are not readily harmed by the action of cytotoxic antibody, whereas others are relatively sensitive (8) . Cytotoxic antibody is particularly effective in damaging white cells, including lymphocytes, and bone marrow. But in our study, neither spleen nor thymus weights nor counts of circulating white and mononuclear cell in the fetus were measurably changed from control values. These parameters were chosen because we believed they would be as sensitive indicators of possible effects of cytotoxic antibody in the fetus as could readily be obtained. Previous studies (2) have shown that there was no difference in fetal mortality rates produced by an immunologically hostile maternal environment. The observations on cytotoxic antibody titers in blastocyst fluid showed that exposure of the embryo to maternal antibody began at a very early stage of development; determinations made on serum obtained from newly born animals showed that the fetus was still exposed to antibody at the time of birth. Nevertheless there was no indication of damage to the offspring. We conclude that the conceptus neither receives nor requires protection by the placental barrier against maternal cytotoxic antibody. We believe that the protective action of the placenta is primarily one of barring the passage of maternal leukocytes. There is considerable evidence (1) that sufficient numbers of foreign leukocytes can damage the immunologically immature fetus or neonatal animal, as demonstrated in the runting syndrome (9) .
The test for cytotoxic antibody produces somewhat different results when applied to rabbits than when used in mice, in which it has found its most extensive use. Cytotoxic antibody has been thought to be effective against only certain types of cells, notably lymphocytes, bone marrow, and various leukemic cells (8) . The target cell used in the titration of cytotoxic antibody is one of these particularly sensitive cells, the lymphocyte. Boyse has shown in mice that it was possible by adjusting the experimental conditions, not only to increase the apparent effectiveness of the antibody against these selected tissues but also to widen the range of its action to include other types of cells previously thought not to be affected. We have been unable to obtain in rabbits the elegant results which Boyse has reported in mice, but have found the test, in the form reported here, to be sufficiently reliable and sensitive for the present purpose. We believe the most critical modification we introduced was the use of our own preparation of rabbit complement in place of commercial guinea pig or rabbit complement. Some factor other than complement itself appeared to be involved, since our preparation had slightly less complement activity than the commercial preparations.
We were surprised at the leukopenia and lymphopenia which we encountered in neonatal rabbits, but the finding was unrelated to maternal immunity against the fetuses. Values of white blood cell and lympocyte counts in the non-sensitized pregnancies were as low as in the sensitized, and we found that others (7) had found similar low values in normal newborn rabbits. We are not aware of an explanation for this apparently physiologic neonatal leukopenia and lymphopenia in this species.
SUMMARY AND CONCLUSIONS
The mammalian fetus affaxed to the uterine wall in some ways resembles a homograft, but maternal homograft immunity even when specifically directed against her fetuses fails to destroy them. The placental barrier appears to be critical in protecting the fetus against maternal immunologic attack. In order to evaluate the means by which it affords protection, we have measured in rabbits the transfer of cytotoxic antibody from mother to fetus. When the offspring were not the specific targets for maternal antibody, we found titers of cytotoxic antibody in the newborn animals at or near maternal levels in 16 of 18 cases (89 per cent), demonstrating the ability of this antibody to cross the rabbit placenta. When the offspring were appropriate targets for antibody, however, 11 of 18 newborn animals (61 per cent) had no demonstrable titer. We believe that in these latter cases, antibody had become fixed to antigenic sites and thereby had been removed from the fetal circulation. There was, however, no evidence of harm to any of the fetuses, either in survival (as demonstrated in a previous study) or in spleen or thymus weights or peripheral leukocyte and mononuclear cell counts.
Cytotoxic antibody appears to reach the embryo early in gestation, since we found antibody in 8-day-old blastocyst fluid in each of 2 trials.
We conclude that the fetus neither receives nor requires protection against cytotoxic antibody, and believe that fetal protection against maternal homograft immunity is afforded by a placental barrier to maternal mononuclear leukocytes.
